Skip to main content
Article
Resectable Distal Pancreas Cancer: Time to Reconsider the Role of Upfront Surgery.
Annals of Surgical Oncology (2018)
  • Daniel W. Nelson, Division of Surgical Oncology, John Wayne Cancer Institute at Providence Saint John’s Health Center, Santa Monica, USA
  • Shu-Ching Chang, Department of Biostatistics, Medical Data Research Center, Providence St. Joseph Health, Portland, USA
  • Gary Grunkemeier, Department of Biostatistics, Medical Data Research Center, Providence St. Joseph Health, Portland, USA
  • Ahmed N. Dehal, Division of Surgical Oncology, John Wayne Cancer Institute at Providence Saint John’s Health Center, Santa Monica, USA
  • David Y. Lee, Department of Surgery, TriHealth Cancer Institute, Cincinnati, USA
  • Trevan D. Fischer, Division of Surgical Oncology, John Wayne Cancer Institute at Providence Saint John’s Health Center, Santa Monica, USA
  • L. Andrew DiFronzo, Kaiser Permanente
  • Victoria V. O’Connor, Kaiser Permanente
Publication Date
December 1, 2018
DOI
10.1245/s10434-018-6765-2
Citation Information
Daniel W. Nelson, Shu-Ching Chang, Gary Grunkemeier, Ahmed N. Dehal, et al.. "Resectable Distal Pancreas Cancer: Time to Reconsider the Role of Upfront Surgery." Annals of Surgical Oncology Vol. 25 Iss. 13 (2018) p. 4012 - 4019
Available at: http://works.bepress.com/shu-ching-chang/33/